PF-07799933

DB17489InvestigationalSmall molecule

PF-07799933 is a BRAF class 2 inhibitor developed by Pfizer.

Mechanism: Pharmacologically active on Serine/threonine-protein kinase B-raf
Curator reviewed
Code names: ARRY-440 · PF-07799933

Resolves to

Compound

Targets

What you can answer from here — as of July 18, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with PF-07799933, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.